[Epidemiology, Mechanisms, and Clinical Challenges of Respiratory Syncytial Virus Co-infections in Children]

Hongyuan Huang1, Huilian Chen1, Lina Qiao1

  • 1( 610041)Department of Pediatrics, West China Second Hospital, Sichuan University, Chengdu 610041, China.

Insights

Respiratory syncytial virus (RSV) co-infections with bacteria or adenoviruses worsen illness in children. Other viral co-infections may prolong sickness but not increase severity, highlighting the need for better RSV treatments.

Area of Science:

  • Pediatrics
  • Virology
  • Epidemiology

Background:

  • Respiratory syncytial virus (RSV) is a major cause of respiratory illness in young children globally.
  • No specific treatment for RSV infection is widely available.
  • The impact of RSV co-infections on disease outcomes is debated despite increased detection.

Purpose of the Study:

  • To investigate the epidemiological features of RSV co-infections.
  • To analyze the clinical implications of RSV co-infections.
  • To explore potential mechanisms behind RSV co-infections.

Main Methods:

  • Epidemiological analysis of RSV co-infections.
  • Clinical data review for co-infected patients.
  • Literature review on molecular mechanisms.

Main Results:

  • RSV co-infections with bacteria or adenoviruses are linked to severe symptoms and complex treatment.
  • Co-infections with other viruses may prolong illness duration but do not necessarily increase severity.
  • Mechanisms underlying RSV co-infections require further elucidation.

Conclusions:

  • RSV co-infections significantly impact disease severity and treatment needs.
  • Further research is crucial for understanding molecular mechanisms.
  • Development of targeted therapies, vaccines, and optimized strategies is essential to reduce RSV disease burden.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.9K
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.7K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.8K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K